SC
Sequoia China
Sequoia China is a seed to growth stage investment firm. It has made 46 investments. They made 1 investments in the last 12 months. Average disclosed round size is $181.6M (across 53 rounds with reported amounts).
Portfolio
46
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
NS
Neil Shen
Founding and Managing Partner
RW
Rock Wang
Partner
TH
Tiantian He
Partner
XL
Xing Liu
Partner
YG
Yuan Gong
Partner
WC
Weihua Cao
Vice President
CT
Christina Tian
Growth Equity Investment
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
68 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| 它它石智航 | Seed | $455M | Apr 2026 |
| Seed | $15M | Jan 2025 | |
| Series B | $50M | Jul 2022 | |
| Series E | $150M | Jul 2021 | |
| Unknown | $150M | Jun 2021 | |
| Unknown | $46.1M | Apr 2021 | |
| Series A | — | Feb 2021 | |
| NNeoX | Series A | $30M | Feb 2021 |
| VVisen | Series B | — | Jan 2021 |
| Unknown | $20M | Jan 2021 | |
| Series C | — | Jan 2021 | |
| RRecBio | Series C | $158M | Jan 2021 |
| Unknown | $2B | Jan 2021 | |
| BBota Biosciences | Series B | $100M | Jan 2021 |
| BBeisen | Series F | $260M | Jan 2021 |
| Series D | $50M | Nov 2020 | |
| Unknown | $84.5M | Jun 2020 | |
| Series D | $24M | Jan 2020 | |
| NNeoX | Series A | $10M | Jan 2020 |
| Growth | $150M | Jan 2020 | |
| Series A | — | Jan 2020 | |
| VViva Republica Inc. | Growth | — | Jan 2020 |
| RRecBio | Series B | $227M | Jan 2020 |
| Series A | $313M | Jan 2020 | |
| MManbang | Growth | $1.7B | Jan 2020 |
Page 1 of 3
Top Co-Investors
B Capital8 shared
5Y Capital6 shared
GGV Capital6 shared
Sky9 Capital5 shared
Lightspeed China Partners5 shared
ZhenFund5 shared
Matrix Partners China5 shared
SoftBank Investment Advisers5 shared
Source Code Capital4 shared
KKR4 shared
IDG Capital4 shared
GSR Ventures4 shared
LYFE Capital4 shared
Pivotal Life Sciences4 shared
ByteDance4 shared
BAI Capital3 shared
Northern Light Venture Capital3 shared
Hillhouse Capital3 shared
Fosun RZ Capital3 shared
YuanBio Venture Capital3 shared
Last updated: 9 September 2026